• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非免疫功能低下神经外科患者中浅白隐球菌导管相关感染的快速诊断与有效治疗。

Prompt diagnosis and effective treatment of Trichosporon asahii catheter-related infection in non-immunocompromised neurosurgical patient.

作者信息

Rubic Zana, Novak Anita, Tomic Zvonimir, Goic-Barisic Ivana, Radic Marina, Tonkic Marija

机构信息

Department of Clinical Microbiology, University Hospital Centre Split, Spinciceva 1, 21000, Split, Croatia,

出版信息

Mycopathologia. 2015 Feb;179(1-2):125-8. doi: 10.1007/s11046-014-9814-9. Epub 2014 Sep 24.

DOI:10.1007/s11046-014-9814-9
PMID:25249355
Abstract

Trichosporon asahii is a rare but emerging fungal pathogen that causes severe and life-threatening infections with high mortality rate, mostly in immunocompromised patients. It could be easily misdiagnosed due to lack of awareness, especially when invasive or deep-seated infections occur in non-immunocompromised patients, and inadequately treated since the clinical failures and high minimum inhibitory concentrations to some antifungal agents have been described. We present a case of T. asahii catheter-related infection in 66-year-old comatose patient with polytrauma, who was not immunodeficient, but was receiving broad-spectrum antibiotics for a long period. Due to prompt diagnosis and treatment which included catheter replacement and voriconazole, the patient successfully recovered from this infection. The aims of this case report were to highlight the importance of recognizing this otherwise colonizing yeast as potentially dangerous pathogen in non-immunocompromised patients with a long-term antibiotic therapy, and to emphasize the importance of the right therapeutic choice due to its resistance to certain antifungal agents.

摘要

阿萨希毛孢子菌是一种罕见但正在出现的真菌病原体,可导致严重且危及生命的感染,死亡率很高,主要发生在免疫功能低下的患者中。由于认识不足,它很容易被误诊,尤其是当非免疫功能低下的患者发生侵袭性或深部感染时,而且由于临床治疗失败以及对某些抗真菌药物的最低抑菌浓度较高,治疗往往不充分。我们报告一例66岁的多发伤昏迷患者发生阿萨希毛孢子菌导管相关感染,该患者无免疫缺陷,但长期接受广谱抗生素治疗。由于及时诊断并进行了包括更换导管和使用伏立康唑在内的治疗,患者成功从感染中康复。本病例报告的目的是强调在长期接受抗生素治疗的非免疫功能低下患者中,认识到这种原本定殖的酵母菌可能是危险病原体的重要性,并强调由于其对某些抗真菌药物耐药,正确选择治疗方法的重要性。

相似文献

1
Prompt diagnosis and effective treatment of Trichosporon asahii catheter-related infection in non-immunocompromised neurosurgical patient.非免疫功能低下神经外科患者中浅白隐球菌导管相关感染的快速诊断与有效治疗。
Mycopathologia. 2015 Feb;179(1-2):125-8. doi: 10.1007/s11046-014-9814-9. Epub 2014 Sep 24.
2
Disseminated Trichosporon asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole. 播散性近平滑念珠菌感染的肝肾联合移植受者经伏立康唑治疗成功。
Immun Inflamm Dis. 2019 Sep;7(3):125-129. doi: 10.1002/iid3.250. Epub 2019 Apr 20.
3
[Nosocomial infection due to Trichosporon asahii in a critical burned patient].[一名严重烧伤患者发生的浅白隐球菌医院感染]
Rev Iberoam Micol. 2015 Oct-Dec;32(4):257-60. doi: 10.1016/j.riam.2014.07.005. Epub 2014 Nov 20.
4
Emerging Trichosporon asahii in elderly patients: epidemiological and molecular analysis by the DiversiLab system.新兴的阿萨希丝曲霉在老年患者中的出现:通过 DiversiLab 系统进行的流行病学和分子分析。
Eur J Clin Microbiol Infect Dis. 2014 Sep;33(9):1497-503. doi: 10.1007/s10096-014-2099-6. Epub 2014 Apr 10.
5
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.新型隐球菌致重症监护病房患者医院获得性泌尿道感染的基因型、毒力因子及药敏试验研究。
J Med Microbiol. 2012 Dec;61(Pt 12):1750-1757. doi: 10.1099/jmm.0.049817-0. Epub 2012 Sep 6.
6
The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.针对阿萨希毛孢子菌、星状毛孢子菌和inkin毛孢子菌临床分离株的动物感染模型及抗真菌药效试验的开发。
Virulence. 2015;6(5):476-86. doi: 10.1080/21505594.2015.1020273. Epub 2015 Mar 9.
7
Exploring the resistance mechanisms in Trichosporon asahii: Triazoles as the last defense for invasive trichosporonosis.探索新型隐球菌的耐药机制:唑类药物作为侵袭性新型隐球菌病的最后防线。
Fungal Genet Biol. 2019 Dec;133:103267. doi: 10.1016/j.fgb.2019.103267. Epub 2019 Sep 9.
8
Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.巴西塞阿拉地区阿萨希毛孢子菌的分离及抗真菌药敏试验
Rev Inst Med Trop Sao Paulo. 2012 Jan-Feb;54(1):1-3. doi: 10.1590/s0036-46652012000100001.
9
Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview.白念珠菌引起免疫功能正常患者皮下真菌感染:病例报告和文献复习。
Braz J Microbiol. 2022 Sep;53(3):1221-1229. doi: 10.1007/s42770-022-00737-x. Epub 2022 Apr 5.
10
Trichosporon asahii infection presenting as chronic meningo-ventriculitis and intra ventricular fungal ball: a case report and literature review.呈现为慢性脑膜脑室炎和脑室内真菌球的阿萨希毛孢子菌感染:1例报告及文献复习
Mycoses. 2015 Feb;58(2):99-103. doi: 10.1111/myc.12282. Epub 2015 Jan 15.

引用本文的文献

1
Microevolution during Chronic Infection May Lead to Coexist with the Host.慢性感染期间的微进化可能导致与宿主共存。
Dermatol Res Pract. 2024 Jul 30;2024:5518156. doi: 10.1155/2024/5518156. eCollection 2024.
2
Integrated transcriptomic analysis of Trichosporon Asahii uncovers the core genes and pathways of fluconazole resistance.整合转录组分析揭示了近平滑假丝酵母氟康唑耐药的核心基因和途径。
Sci Rep. 2017 Dec 19;7(1):17847. doi: 10.1038/s41598-017-18072-9.

本文引用的文献

1
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.ESCMID 和 ECMM 联合临床指南:罕见侵袭性酵母真菌感染的诊断与管理。
Clin Microbiol Infect. 2014 Apr;20 Suppl 3:76-98. doi: 10.1111/1469-0691.12360.
2
Finding the "missing 50%" of invasive candidiasis: how nonculture diagnostics will improve understanding of disease spectrum and transform patient care.发现侵袭性念珠菌病的“缺失的 50%”:非培养诊断如何改善对疾病谱的认识并改变患者治疗。
Clin Infect Dis. 2013 May;56(9):1284-92. doi: 10.1093/cid/cit006. Epub 2013 Jan 11.
3
Successful treatment of Trichosporon asahii infection with voriconazole after bone marrow transplant.
骨髓移植后伏立康唑成功治疗阿萨希毛孢子菌感染。
J Pediatr Hematol Oncol. 2013 Apr;35(3):237-8. doi: 10.1097/MPH.0b013e318279b21b.
4
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.新型隐球菌致重症监护病房患者医院获得性泌尿道感染的基因型、毒力因子及药敏试验研究。
J Med Microbiol. 2012 Dec;61(Pt 12):1750-1757. doi: 10.1099/jmm.0.049817-0. Epub 2012 Sep 6.
5
Nosocomial Trichosporon asahii fungemia in a patient with secondary hemochromatosis: a rare case report.继发于血色病的医院内新生隐球菌血症 1 例:罕见病例报告。
J Microbiol Immunol Infect. 2010 Feb;43(1):77-80. doi: 10.1016/S1684-1182(10)60012-6. Epub 2010 Mar 29.
6
Fatal Trichosporon fungemia in patients with hematologic malignancies.血液恶性肿瘤患者致命性毛孢子菌血症。
Eur J Haematol. 2010 May;84(5):441-7. doi: 10.1111/j.1600-0609.2010.01410.x. Epub 2010 Jan 13.
7
Trichosporon asahii as a prospective pathogen in solid organ transplant recipients.阿萨希毛孢子菌作为实体器官移植受者中的一种潜在病原体。
Mycoses. 2009 May;52(3):263-5. doi: 10.1111/j.1439-0507.2008.01590.x. Epub 2008 Aug 13.
8
Update on the genus Trichosporon.毛孢子菌属的最新进展。
Mycopathologia. 2008 Sep;166(3):121-32. doi: 10.1007/s11046-008-9136-x. Epub 2008 Jun 21.
9
Successful treatment of septic shock with purpura fulminans caused by Trichosporon asahii in an immunocompetent patient.免疫功能正常患者中由浅白隐球菌引起的暴发性紫癜性感染性休克的成功治疗。 (注:原文中病原体有误,应该是“Trichosporon asahii”翻译为“浅白隐球菌”,而不是“Trichosporon asahii”的直接音译,这里按照正确内容进行了翻译调整)
Ann Clin Lab Sci. 2007 Autumn;37(4):366-9.
10
Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.一名急性白血病中性粒细胞减少患者在接受卡泊芬净治疗时发生突破性阿萨希毛孢子菌血症。
Infection. 2008 Feb;36(1):68-70. doi: 10.1007/s15010-007-6278-6. Epub 2007 Sep 19.